This Pharma Magazine is the source for a plethora of unique Pharma articles. Several notable figures from top pharma organisations are featured in the R&D, Manufacturing and Clinical Trials sections, with their expert knowledge of the field.
The pandemic made medicine accessibility challenging worldwide
The pharmaceutical industry has changed dramatically since I first stood at a laboratory bench in the s
Over the last three decades pharma companies have increasingly relied on outsourced research to minimise costs and incorporate new science relating directly to the better understanding of biology
Navigating the complex challenges of bringing new medicines to the marketplace requires both leadership and effective decisionmaking
Screening strategies for small molecules have evolved over decades to pan through thousands of molecules in silico and in highthroughput in vitro assays using the smallest possible amount of compound at minimal cost
Do more better and faster research Scientific researchers have always generally acknowledged the importance of collaboration and sharing of scientific findings to advance scientific innovation
While COVID is not yet behind us there has never been a better time to consider the meaning of national resilience and to prepare for the next threat
Drug discovery and development chevron illustrates various critical phases of progression to develop any molecule for human use
Traumatic events such as date rape drowning or death of loved ones in accidents often necessitate the use of antidepressants for a short treatment course
Gene therapy is a powerful therapeutic approach which relies on the modification or overexpression or suppression of gene expression
In our previous articles we addressed several approaches and concepts which we either identified or developed to contribute to the advancement of the pharmaceutical industry
In recent years clinical research trial designs have started to change from fully paper and brick mortar sites traditional trials to digitalenabled designs utilising decentralised solutions which allow participant visits to be conducted remotely with some visits on site hybrid design or all visit decentralised from designated brickandmortar sites...
Maintaining regulatory compliance in a global marketplace is increasingly challenging as wellestablished regulators and regional local regulators increase their digital capabilities and expectations of Marketing Authorization Holders MAHs
As the biopharmaceutical industry continues to push the boundaries of science Thermo Fisher Scientific is continuing to advocate for the use of new technologies workflows and stronger industry collaborations
India is a major hub for manufacturing and exports of pharmaceutical products
Todays formulation challenges are as diverse as they are demandingfrom increasingly insoluble new chemical entities NCEs to highly bitter drugs to increased regulatory emphasis on patient acceptancearriving at a final dosage form that has commercial potential is a more complex proposition than ever
In Genentech received regulatory approval for Herceptin a monoclonal antibody targeting HER positive breast cancer marking the beginning of the modern personalised healthcare revolution
